title: Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status.
authors.affiliation: Unit of Medical Oncology, Department of Oncology, Ospedale San Donato, Arezzo.
authors.forename: G
authors.initials: G
authors.lastname: Roviello
authors.affiliation: Department of Medical, Surgical and Neurological Sciences, University Hospital of Siena, Radiotherapy Unit, Siena.
authors.forename: C
authors.initials: C
authors.lastname: Pacifico
authors.affiliation: Unit of General and Minimally Invasive Surgery, Surgery and Neuroscience; University of Siena, Siena.
authors.forename: K
authors.initials: K
authors.lastname: Polom
authors.affiliation: Unit of General and Minimally Invasive Surgery, Surgery and Neuroscience; University of Siena, Siena.
authors.forename: F
authors.initials: F
authors.lastname: Roviello
authors.affiliation: Unit of Molecular Therapy and Pharmacogenomic, ASST Cremona, Cremona.|Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Generali
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004943:Esophagogastric Junction; D006801:Humans; D009369:Neoplasms; D013274:Stomach Neoplasms; D000096662:Ramucirumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000096662:Ramucirumab